AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04985175 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Question prompt list
Description: The specific QPS was a one page leaflet for chronic kidney disease which developed by applied literature and public QPL from the National Health Agency. It contains 3 domains 25 questions related to treatment, dialysis, and Kidney transplant. The QPL group participants were asked to read and mark those questions they concerned or write down additional problems.
Study NCT05754658 — intervention group
Intervention type: OTHER
Intervention: Standard of Care
Description: Drugs routinely administered for breast cancer per local standard.
Study NCT05754658 — intervention group
Intervention type: OTHER
Intervention: Standard of Care
Description: Drugs routinely administered for prostate cancer per local standard.
Study NCT06505161 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dry needling
Description: It consists in application of dry needling on active and/or latent TPs in low back multifidus muscles
Study NCT06505161 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Percutaneous electrolysis
Description: It consists in the application of intratissue percutaneous electrolysis with galvanic current as a cathodic flow electrode in the low back multifidus muscles. The intervention will be guided by ultrasound equipment medically certified.
Study NCT05818241 — intervention group
Intervention type: PROCEDURE
Intervention: Treatment of fracture by forearm cast
Description: Patient that are not surgically treated for DRF
Study NCT05818241 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical treatment of fracture
Description: Patients that are surgically treated for DRF
Study NCT06276634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acute Intermittent Hypoxia
Description: During each AIH session, the participant will be equipped with a non-rebreathing face mask, and provided with the AIH intervention. The AIH intervention involves alternating breathing cycles: one with lower oxygen concentration (9-10% Oxygen) than that at sea level (\~21% Oxygen) lasting between 30 and 60 seconds, followed by a similar duration of normal room air (21% Oxygen). This cycle will be repeated 15 times in one session, continuous blood oxygen levels and heart rate will be monitored.
Study NCT05621369 — intervention group
Intervention type: BEHAVIORAL
Intervention: Participant self-assessment surveys
Description: At enrollment, participants are asked to complete a baseline health history, family history, and a participant-reported symptom inventory.
Study NCT05621369 — intervention group
Intervention type: BEHAVIORAL
Intervention: Psoriasis Draw
Description: Participants are asked to draw the location and size of psoriasis they currently experience. Participants are provided a body template onto which they can draw on their screen. Investigators estimate the percentage of body area affected.
Study NCT05621369 — intervention group
Intervention type: BEHAVIORAL
Intervention: Psoriasis Area Photo
Description: Participants are asked to take a picture of a representative psoriasis plaque and indicate the location of the plaque. They are asked to take a picture of the same area over time. The investigators are developing computer vision algorithms to assess the plaque.
Study NCT06327295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB1651-102- Cohort 1
Description: Dosage form- Topical solution; Dosage- 3% formulation The participants will apply the daily dose of 3% ATB1651 once daily to the affected great toenail for 12 weeks with a follow-up for 24 weeks.
Study NCT06327295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB1651-102- Cohort 2
Description: Dosage form- Topical solution; Dosage- 3% formulation The participants will apply the daily dose of 3% ATB1651 once daily to the affected great toenail for 20 weeks with a follow-up for 16 weeks.
Study NCT06327295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB1651-102- Cohort 3
Description: Dosage form- Topical solution; Dosage- 3% formulation The participants will apply the daily dose of 3% ATB1651 twice daily to the affected great toenail for 12 weeks with a follow-up for 24 weeks.
Study NCT06276634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham-Acute Intermittent Hypoxia
Description: During each Sham-AIH session, the participant will be equipped with a non-rebreathing face mask, and provided with the Sham-AIH intervention. The Sham-AIH intervention involves alternating breathing cycles: both with oxygen concentrations of \~21% Oxygen lasting between 30 and 60 seconds, followed by another similar duration of normal room air (21% Oxygen). This cycle will be repeated 15 times in one session, continuous blood oxygen levels and heart rate will be monitored.
Study NCT05621369 — intervention group
Intervention type: BEHAVIORAL
Intervention: Finger and Toe Photos
Description: Participants are asked to take pictures of the back of each hand and the top of each foot. These photos can be used to assess finger and toe swelling as well as psoriatic nail involvement. The investigators are developing computer vision algorithms to assess psoriatic nail involvement and digit swelling.
Study NCT05621369 — intervention group
Intervention type: BEHAVIORAL
Intervention: Digital Jar Open
Description: Participants are asked to internally and externally rotate the phone as it rests on a flat surface. Participants perform each direction (internal and external) and each arm (left and right) in turn. Gyroscope sensors measure the degree of rotation.
Study NCT05621369 — intervention group
Intervention type: BEHAVIORAL
Intervention: 30 Second Walk
Description: Participants are asked to walk in a straight line for 30 seconds. Gait is measured by gyroscope and accelerometer sensors. The investigators examine step-dependent and sequence-dependent features from these sensors. The investigators apply feature selection and classifier algorithms to analyze these data.
Study NCT05621369 — intervention group
Intervention type: OTHER
Intervention: Psorcast mobile application
Description: Participants complete all described behavioral interventions via a dedicated iPhone app, Psorcast.
Study NCT06440733 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program focused in elderly.
Description: Each of these sessions will be carried out taking into account the main physiotherapy objectives, such as gaining strength in both upper and lower limbs, as well as proprioception, balance, and promoting a pleasant and safe social environment where these older people feel valid.~All sessions will begin with a 5-minutes. It will begin with a general warm-up based on general joint mobility of the head and neck, shoulders, trunk, elbows, hands, wrists, hips, knees and ankles to begin to accustom the body to the physical work environment. And at the end of the sessions, a stretching program will be carried out, and it will end with a return to calm with a respiratory training program, in which you will be instructed to take in air through the nose and release it through the mouth, while the room is silent, and thus promote self-awareness.
Study NCT06376591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vit B12
Description: Sucrosomial® B12
Study NCT06376591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vit B12
Description: B-SUB® B12
Study NCT06376591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vit B12
Description: Mecogen SL® B12
Study NCT06376591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vit B12
Description: Evermin® B12
Study NCT06376591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vit B12
Description: Neuromax® B12
Study NCT06355089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Low-protein milk product
Study NCT06327295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB1651-102- Cohort 4
Description: Dosage form- Topical solution; Dosage- 5% formulation The participants will apply the daily dose of 5% ATB1651 once daily to the affected great toenail for 12 weeks with a follow-up for 24 weeks.
Study NCT06327295 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: participants will receive matching placebo across cohorts 1-4 of the study.
Study NCT06355089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey protein hydrolysate milk product
Description: Milk product with whey protein hydrolysate
Study NCT06355089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Postbiotic and whey protein hydrolysate milk product
Description: Milk product with whey protein hydrolysate and Lacticaseibacillus rhamnosus GG
Study NCT05760742 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MicAlgae
Description: 2 months of supplementation with an innovative microalgae based ingredient
Study NCT05760742 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 months of supplementation with a placebo (Maltodextrin)
Study NCT05864573 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ZGGS15
Description: ZGGS15 for dose escalations are set as 0.3 mg/kg, 1 mg/kg, 3 mg/kg, 10 mg/kg, 20 mg/kg, and 30 mg/kg, intravenous infusion, once every 3 weeks.
Study NCT06057519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optimised dose rifampicin
Description: Optimized dose of rifampicin
Study NCT06057519 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard dose rifampicin
Description: Standard dose rifampicin
Study NCT05490147 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional tidal volume (tidal volume [ml]= ideal body weight [kg]* 10~12) group
Description: In the conventional tidal volume group, patients are ventilated with a tidal volume \[ml\]= ideal body weight \[kg\]\* 10\~12.
Study NCT05490147 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: low tidal (tidal volume [ml]= ideal body weight [kg] * 6~8) volume
Description: In the low tidal volume group, patients are ventilated with a tidal volume \[ml\]= ideal body weight \[kg\]\* 6\~8.
Study NCT05531734 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NaoX Intra-Auricular Device (IAD) monitoring EEG data
Description: Intrauaricular measurement tool developed by NaoX Technology to retrieve EEG type data.
Study NCT05531734 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simple psychometric tests
Description: Associated with simple and self-managed psychometric tests.
Study NCT03707418 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin Sodium
Description: Intravenous Heparin titrated to Partial ThromboplastinTime (PTT) levels
Study NCT03707418 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bivalirudin Injection [Angiomax]
Description: Intravenous Bivalirudin titrated to Activated Clotting Time (ACT) levels
Study NCT06414759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Description: Acetazolamide is a medication that belongs to the class of carbonic anhydrase inhibitors. It acts by reducing the reabsorption of sodium in the proximal tubules of the kidneys. When combined with loop diuretics, acetazolamide has the potential to enhance the effectiveness of diuretic therapy, thus aiding in the process of decongestion.~It will be given 500mg orally, once daily.
Study NCT06414759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metolazone
Description: Metolazone is a medication with properties like thiazide diuretics, prescribed for the management of congestive heart failure and hypertension. Its mechanism of action involves blocking the transport of sodium across the epithelium of renal tubules, predominantly in the distal tubules.~It will be given 5mg orally, once daily.
Study NCT06414759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Loop Diuretics
Description: IV loop diuretic 2 times the outpatient oral (PO) daily dose, and oral loop diuretics will be stopped. In cases where the patient was not previously on oral diuretics, a starting dose of 40 mg of IV furosemide, IV bumetanide 1 mg or a bolus of 20 mg of IV torsemide can be utilized.
Study NCT05525234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide
Description: Start with oral thalidomide at 50mg/day, increase or decrease the dose according to itching relief, the maximum dose is 100mg/day
Study NCT05037721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gargling with green tea
Description: experimental group using 0.5% green tea gargle, control group use clear water gargle, secondary in daily use mouthwash after breakfast and lunch after 30 minutes, 15 ml each use gargle for 30 seconds, total 7 days
Study NCT05037721 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: gargling with water
Description: using water gargle, control group use clear water gargle, secondary in daily use mouthwash after breakfast and lunch after 30 minutes, 15 ml each use gargle for 30 seconds, total 7 days
Study NCT04137978 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ADV7103
Description: Patients receive ADV7103 twice a day at optimal dose.
Study NCT04137978 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Cohort of patients with cystinuria, matching-pair for age category to the patients of ADV7103 Cohort, will receive their own alkalinising treatment (SoC) taken at the usual dose and frequency and will follow their usual first intention treatment (hydration and diet) for a 2-year-period.
Study NCT05525234 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Start with oral placebo at 50mg/day, increase or decrease the dose according to itching relief, the maximum dose is 100mg/day
Study NCT00793377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen
Description: Adriamycin will be given at a dose 50 mg/m2 and docetaxel at a dose of 75 mg/m2 every 14 days for four cycles.Tamoxifen 20 mg is given once daily for five years to all patients, starting with the first day of chemotherapy.
Study NCT00793377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Cyclophosphamid
Description: Adriamycin will be given at a dose of 60 mg/m2 and cyclophosphamide at a dose of 600 mg/m2 every 21 days for four cycles. Thereafter, docetaxel at a dose of 100 mg/m2 is given every 21 days for four cycles. Tamoxifen 20 mg is given once daily for five years to all patients, starting with the first day of chemotherapy.
Study NCT05943210 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Short Course Radiation Therapy (scRT)
Description: Eligible patients will receive short course radiation therapy (scRT) of 25Gy over 5 days (fractions) for their localized rectal cancer. Research bloods stool and tissue will be collected at three time points: Baseline, end of radiation therapy and at surgery.
Study NCT05943210 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Total Mesenteric Excision (TME)
Description: Subjects are expected to undergo total mesenteric Excision(TME) even if subjects have achieved complete response by imaging.TME is a specific surgical technique used in the treatment of rectal cancer in which the bowel with the tumor is entirely removed along with surrounding fat and lymph nodes.
Study NCT00012636 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Computer generated statements about guideline concordance of drug therapy deliver to clinicians
Study NCT04782700 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Steroid Taper (Prednisone)
Description: The patients randomized to the steroid group will be prescribed prednisone PO or an equivalent corticosteroid at a dose of 0.5 mg/kg/day for 4 weeks ((plus BACTRIM-DS (1PO qd. 160/800mg) as prophylaxis against infection - If patient have a sulfa allergy, their physician will prescribe atovaquone 1500mg qd instead of Bactrim) and followed by a gradual taper of 0.25 mg/kg/day for 4 weeks, followed by 0.125 mg/kg qd for 4 weeks.
Study NCT05338112 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tzanck smear
Description: The Tzanck smear is gently taken with a sterile scalpel from the ground of erosion or bullous lesions of pemphigus vulgaris. The sample taken is examined by staining the slide.
Study NCT06182046 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Complete decongestive treatment program
Description: It consists of manual lymph drainage, multi-layer bandaging, skin/nail care and exercise treatments. The treatment will last 45 minutes/session, 5 sessions/week and 3 weeks.
Study NCT06182046 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Complete decongestive treatment program
Description: It consists of manual lymph drainage, multi-layer bandaging, skin/nail care and exercise treatments. The treatment will last 45 minutes/session, 5 sessions/week and 3 weeks.
Study NCT06182046 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Balance exercises
Description: These exercises will be performed in 2 sets, 5 days a week for 3 weeks. Each set will last 15 minutes. It will take 15 sessions in total. These exercises include 10 balance exercise movements performed on a bosu ball.
Study NCT05177900 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Study Tool Computer
Description: Nonconventional pulses delivered with custom-ware designed by Boston Scientific
Study NCT05177900 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Study Tool Computer
Description: Nonconventional pulses delivered with custom-ware designed by Boston Scientific
Study NCT05659550 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Honeywell HT-900 Turbo Force Air Circulator
Description: This is a basic, portable, household fan with a single cost of CDN$21.99.
Study NCT05659550 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Honeywell HT-900 Turbo Force Air Circulator
Description: This is a basic, portable, household fan with a single cost of CDN$21.99.
Study NCT06202157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LMB
Description: A baseline blood sample (t=0) is collected from each participant prior to the intervention (LMB), and subsequent blood samples are collected at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours post-intervention.
Study NCT06202157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DHB
Description: A baseline blood sample (t=0) is collected from each participant prior to the intervention (DHB), and subsequent blood samples are collected at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours post-intervention.
Study NCT05260645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Back School
Description: Intervention was carried out for 8 weeks with a frequency of two sessions per week, with a total of 16 sessions lasting 45 min. Of all the sessions, 14 had a practical focus and the other two had a theoretical focus. In the practical part, strengthening and stretching exercises were performed. In the theoretical part, self-management and pain neuroscience education were performed.
Study NCT05400031 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: propolis
Description: After obtaining written consent, oral identification of all participants will be performed prior to randomization. Oral diagnosis of children receiving chemotherapy will be repeated on day 0, day 5, and day 10, and the difference between the Oral Mucositis Rating Scale mean scores of the children in the groups will be examined.~Oral Mucositis Assessment: Oral Mucositis Rating Scale will be used. The oral mucosa of children will be evaluated using the World Health Organization Oral Mucositis Classification.
Study NCT05400031 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05865275 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-level laser treatment
Description: a single preliminary treatment for a few seconds for each tooth using low level diode laser before of tooth bleaching could reduce risk to arise of tooth sensitivity
Study NCT05865275 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: tooth bleaching procedure
Description: The gingival tissues of the teeth to be bleached were isolated from the bleaching gel using a light-cured resin dam (OpalDam Kit, Ultradent; Milan, Italy). A 38 % ready-to-use Hydrogen peroxide-containing gel (The Smile® Strong, Italy) was applied from the first premolar right to the first premolar left of both jaws for a total period of 20 minutes for a 1 single whitening session.
Study NCT05865275 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tooth bleaching procedure
Description: The gingival tissues of the teeth to be bleached were isolated from the bleaching gel using a light-cured resin dam (OpalDam Kit, Ultradent; Milan, Italy). A 38 % ready-to-use Hydrogen peroxide-containing gel (The Smile® Strong, Italy) was applied from the first premolar right to the first premolar left of both jaws for a total period of 20 minutes for a 1 single whitening session.
Study NCT05660824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stromal Vascular Fraction infiltration
Description: Procedure to prepare SVF: In the operations room and after aseptic technic, local anesthesia is applied in the liposuction incision site with lidocaine 1% without epinephrine subcutaneously. 60 ml of tumescent solution are injected. After 15-20 minutes waiting, 15 ml of lipoaspiration per side are recollected into a double syringe. This is centrifuged for 4 minutes at 2.500 rpm and the remaining fat is separated from the other fractions. Two 1.4 mm GEMS syringes are attached together, and fat is transferred at least 30 times from one syringe to the other. Syringe content is again centrifugated for 4 minutes. The oil is discarded and approximately 1.5ml SVF fraction remains.